5767 |
ASSURE-DES Trial |
Jung-Min Ahn |
Apr. 20. 23 |
5766 |
TAILRORED-CHIP Trial |
Duk-Woo Park |
Apr. 20. 23 |
5765 |
PREVENT Trial |
Seung-Jung Park |
Apr. 20. 23 |
5764 |
OCTIVUS Trial |
Do-Yoon Kang |
Apr. 20. 23 |
5763 |
Anticoagulation vs. Antiplatelet After TAVR: ADAPT-TAVR Trial |
Duk-Woo Park |
Apr. 20. 23 |
5762 |
10-Year Extended Follow-up of BEST Trial |
Jung-Min Ahn |
Apr. 20. 23 |
5761 |
Routine Functional Testing or Standard Care in High-Risk Patients after PCI |
Do-Yoon Kang |
Apr. 20. 23 |
5760 |
Moderate-intensity Statin + Ezetimibe versus High-intensity Statin Monotherapy in ASCVD: RACING Trial |
Myeong-Ki Hong |
Apr. 20. 23 |
5759 |
Intravascular Imaging–Guided or Angiography-Guided Complex PCI: RENOVATE-COMPLEX-PCI |
Joo-Yong Hahn |
Apr. 20. 23 |
5758 |
FFR vs. IVUS to Guide PCI |
Bon-Kwon Koo |
Apr. 20. 23 |